Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Mantle Cell Lymphoma
Related studies linked through entity extraction aliases.
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
- Status
- RECRUITING
- Phase
- PHASE1
Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)
- Status
- COMPLETED
- Phase
- NA
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Evaluating Different Doses of Orelabrutinib in MCL
- Status
- RECRUITING
- Phase
- PHASE2
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE3
A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1
FT596 in Combination With R-CHOP in Subjects With B-Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
A Food Effect Study of LP-168 Tablets in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With Prior BTK Inhibitor Exposure.
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Tafasitamab and Lenalidomide in People With Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel
- Status
- AVAILABLE
- Phase
- N/A
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
- Status
- RECRUITING
- Phase
- N/A
Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2